QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barclays-maintains-equal-weight-on-privia-health-gr-raises-price-target-to-22

Barclays analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight and raises the price target from $2...

 privia-health-acquires-evolents-aco-business-to-boost-value-based-care

Privia Health (PRVA) to acquire Evolent Health's (EVH) ACO business for $100M, expanding its value-based care footprint.

 stephens--co-reiterates-overweight-on-privia-health-gr-maintains-32-price-target

Stephens & Co. analyst Jeff Garro reiterates Privia Health Gr (NASDAQ:PRVA) with a Overweight and maintains $32 price ta...

 stephens--co-reiterates-overweight-on-privia-health-gr-maintains-32-price-target

Stephens & Co. analyst Jeff Garro reiterates Privia Health Gr (NASDAQ:PRVA) with a Overweight and maintains $32 price ta...

 jmp-securities-maintains-market-outperform-on-privia-health-gr-raises-price-target-to-30

JMP Securities analyst David M. Scharf maintains Privia Health Gr (NASDAQ:PRVA) with a Market Outperform and raises the pric...

 piper-sandler-maintains-overweight-on-privia-health-gr-lowers-price-target-to-35

Piper Sandler analyst Sean Wieland maintains Privia Health Gr (NASDAQ:PRVA) with a Overweight and lowers the price target fr...

 privia-health-gr-affirms-fy2025-sales-guidance-of-1800b-1900b-vs-3242b-est

Privia Health Gr (NASDAQ:PRVA) affirms FY2025 sales outlook from $1.800 billion-$1.900 billion to $1.800 billion-$1.900 billion...

 privia-health-gr-q2-adj-eps-024-beats-005-estimate-sales-521153m-miss-800104m-estimate

Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.0...

 evercore-isi-group-maintains-outperform-on-privia-health-gr-lowers-price-target-to-28

Evercore ISI Group analyst Elizabeth Anderson maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and lowers the pric...

 jp-morgan-maintains-overweight-on-privia-health-gr-raises-price-target-to-32

JP Morgan analyst Lisa Gill maintains Privia Health Gr (NASDAQ:PRVA) with a Overweight and raises the price target from $29 ...

 barclays-maintains-equal-weight-on-privia-health-gr-raises-price-target-to-24

Barclays analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight and raises the price target from $2...

 privia-health-gr-affirms-fy2025-sales-guidance-of-180b-190b-vs-322b-est

Privia Health Gr (NASDAQ:PRVA) affirms FY2025 sales outlook from $1.80 billion-$1.90 billion to $1.80 billion-$1.90 billion vs ...

 privia-health-gr-q1-adj-eps-022-beats-005-estimate-sales-48010m-miss-77708m-estimate

Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.0...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION